Department of Thoracic Surgery, The School of Clinical Medicine, The First Hospital of Putian, Fujian Medical University, Putian, 351100, China.
Department of Critical Care Medicine, Jinjiang Municipal Hospital, Quanzhou, 362299, China.
J Cardiothorac Surg. 2024 Oct 4;19(1):590. doi: 10.1186/s13019-024-03086-y.
This study aims to evaluate the long-term outcomes of compensatory hyperhidrosis (CH) after thoracoscopic sympathectomy and explore the risk factors affecting postoperative CH in primary palmar hyperhidrosis(PPH) patients.
A retrospective analysis was conducted on patients who underwent thoracoscopic sympathectomy in the thoracic surgery department of our hospital from January 2015 to May 2022. Long-term follow-up surveys was conducted to collect data on post-operative satisfaction, PPH recurrence, and CH occurrence. Postoperative CH outcomes were assessed using the HDSS and satisfaction scores scale. Univariate and multivariate logistic regression analyses were used to identify independent risk factors for postoperative CH.
A total of 152 patients was included in the final study, with 113 cases in the CH group and 39 cases in the nCH group. The incidence of postoperative CH was 74.3% (113/152), within which 33.6% (38/113) were severe CH. The median follow-up time was 3.1 years(2.5-5.5y) and the median interval of CH onset after surgery was 30 days (14-90d). Univariate analysis showed that body mass index(BMI), surgical time, and transected nerve level are correlated with CH, with statistically significant differences. Multivariate logistic regression analysis indicated a higher BMI (OR = 0.864, 95% CI 0.755-0.989, P < 0.05) is the independent risk factor for the occurrence of CH. There was no statistically significant difference in HDSS scores among CH patients at 1 month, 1 year, and 3 years after surgery.
A higher BMI is the independent risk factor for postoperative CH after thoracoscopic sympathectomy. The incidence and severity of postoperative CH kept stable during a long term follow up.
本研究旨在评估胸腔镜交感神经切断术后代偿性多汗(CH)的长期疗效,并探讨原发性手掌多汗症(PPH)患者术后发生 CH 的相关风险因素。
回顾性分析 2015 年 1 月至 2022 年 5 月我院胸外科行胸腔镜交感神经切断术的患者,通过长期随访收集术后满意度、PPH 复发和 CH 发生情况。术后 CH 结局采用 HDSS 和满意度评分量表进行评估。采用单因素和多因素 logistic 回归分析确定术后 CH 的独立危险因素。
最终共纳入 152 例患者,CH 组 113 例,nCH 组 39 例。术后 CH 发生率为 74.3%(113/152),其中 33.6%(38/113)为重度 CH。中位随访时间为 3.1 年(2.5-5.5 年),术后 CH 发病中位时间为 30 天(14-90d)。单因素分析显示,BMI、手术时间和切断神经水平与 CH 相关,差异有统计学意义。多因素 logistic 回归分析表明,较高的 BMI(OR=0.864,95%CI 0.755-0.989,P<0.05)是 CH 发生的独立危险因素。术后 1 个月、1 年和 3 年,CH 患者的 HDSS 评分差异无统计学意义。
较高的 BMI 是胸腔镜交感神经切断术后发生 CH 的独立危险因素。术后 CH 的发生率和严重程度在长期随访中保持稳定。